Navidea生物制药(NAVB)

1.75 0.05 2.9412%

今开:1.7昨收:1.7
最高:1.79 最低:1.67
涨停价:0.0跌停价:0.0
总市值:5.2785679E7

Navidea生物制药的热门评论

Navidea生物制药(NAVB)05-14 04:12

$Navidea生物制药(NAVB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-012043 Act: 34 Size: 5 MB 网页链接查看全文

Navidea生物制药(NAVB)05-14 04:45

$Navidea生物制药(NAVB)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001437749-21-012089 Act: 33 Size: 391 KB 网页链接查看全文

Navidea生物制药(NAVB)05-12 04:42

$Navidea生物制药(NAVB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-011697 Act: 34 Size: 100 KB 网页链接查看全文

Navidea生物制药(NAVB)05-12 04:18

$Navidea生物制药(NAVB)$ 8-K Current report, item 5.02 Accession Number: 0001437749-21-011698 Act: 34 Size: 20 KB 网页链接查看全文

Navidea生物制药(NAVB)2020-09-03 05:06

$Navidea生物制药(NAVB)$ 8-K Current report, items 1.01, 5.03, and 9.01 Accession Number: 0001437749-20-019237 Act: 34 Size: 448 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)09-18 04:48

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-022353 Size: 4 KB 网页链接查看全文

当期报告

Navidea生物制药(NAVB)09-17 20:06

$Navidea生物制药(NAVB)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001437749-21-022300 Act: 34 Size: 184 KB 网页链接查看全文

季度财报

Navidea生物制药(NAVB)08-13 05:12

$Navidea生物制药(NAVB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-019756 Act: 34 Size: 6 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Navidea生物制药的最新评论

持股变动声明

Navidea生物制药(NAVB)09-18 04:48

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-022353 Size: 4 KB 网页链接查看全文

当期报告

Navidea生物制药(NAVB)09-17 20:06

$Navidea生物制药(NAVB)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001437749-21-022300 Act: 34 Size: 184 KB 网页链接查看全文

季度财报

Navidea生物制药(NAVB)08-13 05:12

$Navidea生物制药(NAVB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-019756 Act: 34 Size: 6 MB 网页链接查看全文

当期报告

Navidea生物制药(NAVB)08-12 04:27

$Navidea生物制药(NAVB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-019466 Act: 34 Size: 133 KB 网页链接查看全文

股东委托书协议

Navidea生物制药(NAVB)08-02 19:36

$Navidea生物制药(NAVB)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-21-018064 Act: 34 Size: 626 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)07-27 21:03

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-017568 Size: 4 KB 网页链接查看全文

Navidea生物制药(NAVB)07-27 07:33

$Navidea生物制药(NAVB)$ 内部交易: 2021-07-26,Director,Witter Malcolm G ,买入,15000普通股, $1.70查看全文

首次持股声明

Navidea生物制药(NAVB)07-14 06:42

$Navidea生物制药(NAVB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-016871 Size: 2 KB 网页链接查看全文

当期报告

Navidea生物制药(NAVB)07-14 04:21

$Navidea生物制药(NAVB)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001437749-21-016842 Act: 34 Size: 59 KB 网页链接查看全文

持股变动声明

Navidea生物制药(NAVB)07-08 06:00

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-016596 Size: 4 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Navidea生物制药的公告

$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-08-16 AccNo: 0001437749-18-015733 Size: 36 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 9.01: Financial Statements and Exhibits ht...

$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-08-15 AccNo: 0001437749-18-015682 Size: 25 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ...

$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-08-09 AccNo: 0001437749-18-015009 Size: 188 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Navidea Biopharmaceuticals, Inc.(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-08 AccNo: 0001437749-18-014956 Size: 7 MB 网页链接

$Navidea Biopharmaceuticals, Inc.(NAVB)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-07-20 AccNo: 0001437749-18-013527 Size: 67 KB 网页链接

$Navidea Biopharmaceuticals, Inc.(NAVB)$ DEF 14A - Other definitive proxy statements Filed: 2018-07-09 AccNo: 0001437749-18-013138 Size: 1 MB 网页链接

$Navidea Biopharmaceuticals, Inc.(NAVB)$ PRE 14A - Other preliminary proxy statements Filed: 2018-06-07 AccNo: 0001437749-18-011441 Size: 1 MB 网页链接

$Navidea Biopharmaceuticals, Inc.(NAVB)$ SD - Filed: 2018-05-31 AccNo: 0001437749-18-010994 Size: 16 KB 网页链接

$Navidea Biopharmaceuticals, Inc.(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-09 AccNo: 0001437749-18-009223 Size: 6 MB 网页链接

$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-05-08 AccNo: 0001437749-18-009054 Size: 145 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33